Nuvalent, Inc. (NUVL) has a market capitalization of $7.69B and trades at $105.02. The 52-week range is 55.535-113.015.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -18, Earnings Per Share (EPS) of $-5.85.
The stock has a beta of 1.31, operates in the Healthcare sector.